Serological Cancer Markers

This latest volume edited by Stewart Sell provides up-to-the-minute information on the clinical use of cancer markers-focusing on those detected in the serum-for the diagnosis of cancer, as well as for monitoring various aspects of patients' progress and prognosis. These markers can be detected by monoclonal antibodies and molecular probes. Serological Cancer Markers takes into account the rapid growth in applications of these cancer marker assays that have recently been developed. Experts in cancer research have contributed chapters that cover a wide range of tests and other information, including: - carbohydrate epitopes - mucin epitopes - cytoplasmic proteins - alkaline phosphatases - sex-linked hormones - alphafetoprotein - myeloma paraprotein - reagents for measuring cancer markers - detection of hidden lesions by specific direction of radioisotopes - marketability of new cancer products - multiple testing with cancer markers - future trends. Stewart Sell's new Serological Cancer Markers is an indispensable, state-of-the-art resource for everyone involved in cancer research, clinical oncology, and related fields.